The FTC filed a lawsuit to block AMGEN from buying Horizon Therapeutics. Jen Schulder: People were pretty shocked because for the past 10 years the FTC is routinely okay deals like this. She says if any deal is more than $20 billion we're going to sue to block it.Schulder: They just don't want any big deals done.
Bloomberg Intelligence Senior Litigation Analyst, Jennifer Rie and Bloomberg Antitrust Reporter Leah Nylen discuss the latest with the FTC’s suit to block Amgen’s deal with Horizon Therapeutics. Mary Lou Gardner, Associate Partner for CPG, Retail and Logistics at Infosys Consulting discusses consumer outlook in retail. Bloomberg Businessweek Editor Joel Weber and Bloomberg Editorial Senior Commodities Reporter James Attwood discuss the green energy transition and Chile’s copper problem. And we Drive to the Close with Hank Smith, CIO of Haverford Trust.
Hosts: Carol Massar and Matt Miller. Producer: Sara Livezey
See omnystudio.com/listener for privacy information.